Effect of Alternate-Day Hydrocortisone Therapy on the Immunologically Immature Rat. I: Effect on Blood Cell Count,Immunoglobulin Concentrations,and Body and Organ Weights
Free accessResearch articleFirst published online June, 1993
Effect of Alternate-Day Hydrocortisone Therapy on the Immunologically Immature Rat. I: Effect on Blood Cell Count,Immunoglobulin Concentrations,and Body and Organ Weights
The effect of 400 mg/M2/day of hydrocortisone, given alternatively from day 7 to day 19, was studied in the immunologically immature rat, a steroid-sensitive species. Animals, sacrificed 2 days following the completion of treatment, suffered from an underweight thymus and spleen, leucocytosis, and peripheral lymphocytopenia, probably not due to redistribution of lymphocytes from blood to tissues. In addition, a significant decrease in serum IgM concentration, reflecting a deficit in primary immune response, was evidenced. Although the percentage of lymphocytes returned to normal in rats sacrificed 23 days after treatment, an overweight thymus and spleen and persistent leucocytosis may reflect a compensatory overactivity of the developing immune system. In contrast, serum IgM concentration increased, but to a value less than normal. An indirect effect of hydrocortisone on lymphocytes through its action on thymus, as well as a direct effect on B cells, is suggested. Unlike humans, alternate-day steroid therapy delayed the normal growth pattern of rat, with a defective rate of growth only during the treatment period.
1. Antopol W (1950). Anatomic changes produced in mice treated with excessive doses of cortisone. Proc. Soc. Exp. Med.73: 262–265.
2.
2. Arnason BG, DeVaux St-Cyr C, and Relyveld EH (1964). Role of thymus in immune reactions in rats. IV. Immunoglobulins and antibody formation. Int. Arch. Allergy25: 206–224.
3.
3. Amason BG, Jankovic BD, Waksman BH, and Wennersten C (1962). Role of the thymus in immune reactions in rats. II. Suppressive effect of thymectomy at birth on reactions of delayed (cellular) hypersensitivity and the circulating small lymphocyte. J. Exp. Med.116: 177–186.
4.
4. Bacon GE and Spencer ML (1973). Pediatric uses of steroids. Med. Clin. North Ant.57: 1265–1276.
5.
5. Berglund K (1956). Studies on factors which condition the effect of cortisone on antibody production. 1. The significance of time of hormone administration in primary hemolysin response. Acta Pathol. Microbiol. Scand.38: 311–328.
6.
6. Bemey S (1974). Characterization of glucocorticoid-induced change in lymphocyte circulation in the rat.Clin. Res.22: 414A.
7.
7. Branceni D and Arnason BG (1966). Thymic involution and recovery: Immune responsiveness and immunoglobulins after neonatal prednisolone in rats. Immunology10: 35–44.
9. Byron MA, Jackson J, and Ansell BM (1983). Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis. J. R. Soc. Med.76: 452–457.
10.
10. Carter PB and Bazin H (1980). Immunology. In: The Laboratory Rat, Vol. II, HJ Baker, JR Lindsey, and SH Weisbroth (eds). Academic Press, San Diego, CA, pp. 181–212.
11.
11. Chai H and Gilbert MT (1973). The effect of alternate-day prednisone on the white blood count in children with chronic asthma. J. Allergy Clin. Immunol.51: 65–70.
12.
12. Clark SL (1959). The ingestion of proteins and colloidal materials by columnar absorptive cells of the small intestine in suckling rats and mice. J. Biophys. Biochem. Cytol.5: 41–150.
13.
13. Clark SL and Schneider GB (1973). Role of the adrenal cortex in maturation of the lymphoid system and immunological competence; the effects of aminoglutethimide in suckling mice. Am. J. Anat.137: 231–256.
14.
14. Cohen JJ (1972). Thymus-derived lymphocytes sequestered in the bone marrow of hydrocortisonetreated mice. J. Immunol.108: 841–844.
15.
15. Cohen JJ and Claman HN (1971). Thymus-marrow immunocompetence. V. Hydrocortisone-resistant cells and processes in the hemolytic antibody response of mice. J. Exp. Med.133: 1026–1034.
16.
16. Dale DC, Fauci AS, and Wolff SM (1974). Alternate-day prednisone. Leucocyte kinetics and susceptibility to infections. N. Engl. J. Med.291: 1154–1158.
17.
17. Dluhy RG, Lauler DP, and Thorn GW (1973). Pharmacology and chemistry of adrenal glucocorticoids. Med. Clin. North Am.57: 1155–1165.
18.
18. Esteban JN (1968). The differential effect of hydrocortisone on the short-lived small lymphocytes. Anat. Rec.162: 349–356.
19.
19. Fauci AS (1974). Effect of hydrocortisone on guinea pig peripheral blood lymphocyte subpopulations. Fed. Proc.33: 750.
20.
20. Fauci AS and Dale DC (1974). The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J. Clin. Invest.53: 240–246.
21.
21. Fauci AS and Dale DC (1975). Alternate-day prednisone therapy and human lymphocyte subpopulations. J. Clin. Invest.55: 22–32.
22.
22. Haynes RC (1990). Adrenocortical hormones. In: The Pharmacologic Basis of Therapeutics, 8th ed., AG Gilman, TW Rall, AS Nies, and P Taylors (eds). Pergammon Press, New York pp. 1431–1462.
23.
23. Laron Z and Pertzelan A (1968). The comparative effect of 6 α-fluoroprednisolone, 6 α-methyl-prednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease. J. Pediatr.73: 771–783.
24.
24. Mancini G, Carbonara AO, and Heremans JF (1965). Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry2: 235–254.
25.
25. McEnery PT, Gonzalez LL, Martin LW, and West CD (1973). Growth and development of children with renal transplants. Use of altemate-day steroid therapy. J. Pediatr.83: 806–814.
26.
26. McGhee JR, Michalek SM, and Ghanta VK (1975). Rat immunoglobulins in serum and secretions: Purifications of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva. Immunochemistry12: 817–823.
27.
27. Morrison PR and Meyer MP (1964). Constants for use in surface area formula: Mammals. In: Biology Data Book, PL Altman and DS Dittmer (eds). Federation of American Society for Experimental Biology, Washington, DC, pp. 120–121.
28.
28. Posey WC, Nelson HS, and Pcarlman DS (1978). The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J. Allergy Clin. Immunol.62: 340–348.
29.
29. Preece MA (1976). The effect of administered corticosteroids on the growth of children. Postgrad. Med. J.52: 625–630.
30.
30. Raviola E (1986). The immune system. In: Bloom and Fawcett.—A Textbook of Histology, 11th ed., DW Fawcett (ed). W.B. Saunders, Philadelphia, PA, pp. 406–435.
31.
31. Reichling GH and Klingman AM (1961). Alternate-day corticosteroid therapy. Arch. Derm.83: 980–987.
32.
32. Sadeghi-Nejad A and Senior B (1969). Adrenal function, growth, and insulin in patients treated with corticosteroids on alternate days. Pediatrics43: 277–283.
33.
33. Soyka LF (1967). Treatment of the nephrotic syndrome in childhood. Am. J. Dis. Child.113: 693–701.
34.
34. Soyka LF and Saxena KM (1965). Altemate-day steroid therapy for nephrotic children. JAMA192: 225–230.
35.
35. Spry CJF (1972). Inhibition of lymphocyte recirculation by stress and corticotropin. Cell. Immunol.4: 86–92.
36.
36. Tuchinda M, Ncwcomb RW, and DeVald BL (1972). Effect of prednisone treatment on the human immune response to keyhole limpet hemocyanin. Int. Arch. Allergy42: 533–544.
37.
37. Veerman AJP (1975). The postnatal development of the white pulp in the rat spleen and the onset of immunocompetence against a thymus-independent and a thymus-dependent antigen. Z. Immun.-Forsch.150: 45–59.
38.
38. William GM and Nossal JV (1966). Ontogeny of the immune response. I. The development of the follicular antigen-trapping mechanism. J. Exp. Med: 124: 47–58.
39.
39. Zurier RB and Weissmann G (1973). Anti-immunologic and anti-inflammatory effects of steroid therapy. Med. Clin. North Am.57: 1295–1307.
